Where Medical Expertise Meets Global Clinical Research
Backed by a medical advisory team with 60+ years of trial oversight, BICS delivers full-spectrum CRO services—from Phase I to PV—with a zero-critical-finding track record and dual-site delivery advantage.
Why Sponsors Trust BICS
At Boston International Clini School (BICS), we don’t just offer services — we become your strategic partner in compliant, efficient, and medically-supervised clinical research.
Zero-Critical Audit Record
Over 50 clinical and pharmacovigilance inspections passed since 2019 with no critical findings. Every process is governed by ICH-GCP–aligned SOPs and quality assurance protocols.
Clinician-Led Oversight
All studies at BICS are medically supervised by MBBS/MD professionals with 25+ years of experience. Our senior investigators bring real-world hospital expertise, ensuring protocols are both scientifically sound and ethically grounded.
India + Dubai Trial Network
Sponsors gain access to patient pools and regulatory frameworks across two strategic clinical geographies—India and the UAE. This dual-site capability accelerates startup timelines and expands subject diversity while simplifying regional approvals.
Agile, Mid-Sized Delivery Model
Unlike bloated global CROs, we offer direct access to decision-makers, faster study initiation, and personalized project management. Our lean team model ensures speed without compromise.
Academic Backbone, Operational Excellence
As a CRO powered by a clinical research school, BICS continuously trains its internal teams on evolving global regulations, trial technologies, and quality systems. The result: better-prepared teams, updated SOPs, and smoother audits.
Meet the Leadership Behind Every Trial
Our core leadership team brings medical credibility, regulatory insight, and decades of hands-on trial oversight to every study we run.

Dr. Jitendra Agrawal
Principal Investigator & Medical Director
Qualification:
MBBS, MD (Medicine), Diabetes Certification–Boston University
Experience:
30+ years
-
➤ 80+ national/international trials
➤ Director, Sanjeevan Hospital

Dr. Meena Agrawal
Academic Research & Regulatory Advisor
Qualification:
MBBS, MD (Physiology)
Experience:
30+ years
Highlights:
-
➤ 19+ international publications
➤ Educational Director, Sanjeevan Hospital
➤ Expert in ethics, training, compliance
CRO Services–What We Deliver
Full-service, regulatory-compliant CRO solutions with clinician-led oversight and tech-enabled execution.
Clinical Trials
Phase I-IV, monitoring & SDV, regulatory
Pharmacovigilance
ICSR, PSUR, Signal detection
Therapeutic Expertise
Diabetes, oncology, Dermatology, cardiology
Technology Backbone
CTMS, Dashboards, 21 CRF Part 11
Engagement Models
FSP, Trial Rescue, India + UAE-PI Network
Therapeutic Domain Specialization
At BICS, we support trials and safety studies across diverse therapeutic areas — with a focus on complex conditions, high-growth domains, and regionally relevant diseases.
Our India + UAE trial network, investigator-led model, and regulatory alignment ensure both subject diversity and scientific integrity across every project.
Diabetes & Metabolic Disorders
Ideal sites for long-term endocrinology trials with compliance.
Oncology & Hematology
Protocol-to-closeout support for oncology trials Biosimilar and rare cancer experience Regulatory compliance in fast-paced studies
Infectious Diseases & Vaccines
Experienced in infection trials, vaccine safety, and rapid patient recruitment network.
Nutraceuticals & Herbal Sciences
Specialized in herbal trials, Ayurveda protocols, and cosmetovigilance reporting.
Dermatology & Cosmetology
Expertise in skincare trials with flexible protocols and measurable outcomes.
Cardiology & Critical Care
Hospital-integrated trials with focus on hypertension, ICU endpoints, and real-time safety/data reporting.
Regulatory Alignment & Infrastructure
Built for Audits. Ready for Approvals.
At BICS, regulatory compliance isn’t a phase — it’s our operating standard. Across India and UAE, our trials are governed by ICH-GCP-aligned SOPs, audited sites, and secure, tech-enabled systems.
- 50+ Audits Passed – Zero critical findings
- Ethics Committee–Registered Sites
- ICH-GCP, CDSCO, MOH-UAE Compliant
- 50+ Audits Passed – Zero critical findings
- Ethics Committee–Registered Sites
- ICH-GCP, CDSCO, MOH-UAE Compliant
Engagement Models Built for Flexibility
We adapt to your trial’s complexity and scale—offering models that bring speed, control, and region-specific execution.
Case Highlights / Outcome Snapshots
Real-world results across therapeutic areas and regulatory zones — delivered with medical precision.
Phase III Diabetes Trial–India + UAE
Multi-Country Trial Execution
- 326 patients enrolled in 9 weeks
- 20% budget savings
- Report submitted 18 days early
Oncology Safety Monitoring (PV)
Pharmacovigilance Setup for UAE Market
- PV system lives in 4 weeks
- 0 audit findings
- Certified by MOH
Herbal Skincare Post-Market Study
Herbal Product Regulatory Launch Support
- 92% subject retention
- UAE approval in 1 submission
- PV library created
Ready to Collaborate?
Get in touch to discuss how BICS can support your clinical development needs.